J Eur Acad Dermatol Venereol October 2022 PMID 35648446

Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo-controlled study.

E Sánchez-Meza, J Ocampo-Candiani, M Gómez-Flores, M E Herz-Ruelas, J Ocampo-Garza, T L Orizaga-Y-Quiroga, A Martínez-Moreno, S S Ocampo-Garza

Mentions

5
Peak: 3 in Jun 2022
across 2 sources since Jun 2022

Extended reach

30,741
potential audience

Total likes

305

Video views

24,887

Mentions per month

Jun 2022 – Sep 2024

Where it's discussed

  • X / Twitter3 posts
  • YouTube2 videos

AI synopsis

What people are saying

The discussions primarily revolve around the significance of the combined microneedling and dutasteride approach, with mentions of related treatments like oral minoxidil and broad topics such as sleep issues and pediatric alopecia, showing a curious and somewhat exploratory attitude. The tone suggests interest in potential new therapies, but without strong endorsements or critical dissection, indicating moderate engagement and perceived impact.

AgreementModerate agreement

The discussions acknowledge the relevance of combining microneedling with dutasteride for hair loss treatment, indicating general support or curiosity about the study’s findings.

InterestModerate interest

Participants show moderate interest, as evidenced by their focus on specific treatments like oral minoxidil, dutasteride, and microneedling, and their inclusion in a podcast discussing evidence-based hair loss strategies.

EngagementModerate engagement

The conversations delve into related topics such as sleep issues, endothelial dysfunction, and pediatric alopecia, demonstrating an active but not deeply detailed engagement with the research.

ImpactNeutral impact

While the discussion highlights the potential clinical relevance, the overall tone suggests the impact is still being evaluated or is of emerging importance rather than a definitive breakthrough.

Abstract in brief

  • The study investigates the effectiveness of combining microneedling with topical dutasteride to treat androgenetic alopecia, which is a common form of hair loss.
  • It is a randomized, placebo-controlled clinical trial, meaning participants were randomly assigned to either the treatment or a placebo group to test the true effect of the medication and microneedling.
  • The findings aim to determine whether this combined approach improves hair growth more than placebo, potentially offering a new treatment option for hair loss sufferers.]

Top posts

Most liked on X and Bluesky
Dr. Jeff Donovan,
@DonovanMedical · X

On this week’s Evidence Based Hair Podcast I’ll discuss oral minoxidil, dutasteride microneedling, sleep issues in AGA, endothelial dysfunction in alopecia areata and the rising prevalence of pediatric alopecia areata https://t.co/dwK3VI2WpZ

Jun 7, 2022 · 4 likes · 1 share · 3,478 followers View post →
Hairloss Experiences
@Hairtransplant_ · X

RT @DonovanMedical: On this week’s Evidence Based Hair Podcast I’ll discuss oral minoxidil, dutasteride microneedling, sleep issues in AGA,…

Jun 7, 2022 · 1 share · 2,339 followers View post →

All mentions

Daniel
@DanielM988 · X

https://t.co/1moCoagZ9j

Nov 6, 2023 · 34 followers View post →
Hairloss Experiences
@Hairtransplant_ · X

RT @DonovanMedical: On this week’s Evidence Based Hair Podcast I’ll discuss oral minoxidil, dutasteride microneedling, sleep issues in AGA,…

Jun 7, 2022 · 1 share · 2,339 followers View post →
Dr. Jeff Donovan,
@DonovanMedical · X

On this week’s Evidence Based Hair Podcast I’ll discuss oral minoxidil, dutasteride microneedling, sleep issues in AGA, endothelial dysfunction in alopecia areata and the rising prevalence of pediatric alopecia areata https://t.co/dwK3VI2WpZ

Jun 7, 2022 · 4 likes · 1 share · 3,478 followers View post →